皮洛卡在过敏性鼻炎的管理中
Lydia M Theodoropoulou1, Niamh A Cullen2
1Allergy Associates of La Crosse, Onalaska, Wisconsin. lydiatheon@yahoo.com.
International journal of pharmaceutical compounding
|March 12, 2026
概括
皮洛卡是一种胆药物,通过改善鼻分泌和清除,有效治疗持续过敏鼻炎 (ARS) 症状. 较低剂量的皮洛卡尔在耐火性鼻腔阻塞患者中显示持续缓解症状.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
背景情况:
- 研究过敏性鼻炎 (ARS) 中的胆性缺乏症.
- 评估了肌肉蛋白受体激动剂皮洛卡尔的疗效,用于治疗耐火性阻塞性鼻鼻症状.
- 旨在改善ARS患者的分泌和清除.
研究的目的:
- 评估皮洛卡尔在治疗ARS患者中阻塞性鼻鼻症状方面的有效性.
- 为了确定皮洛卡治疗的最佳剂量和可持续性.
- 评估皮洛卡尔对中鼻结局测试 (SNOT-22) 成绩的影响.
主要方法:
- 对48名严重阻塞性ARS患者进行了回顾性研究.
- 利用22项鼻结局测试 (SNOT-22) 来识别和跟踪症状严重程度.
- 用皮洛卡尔 (5毫克) 治疗的患者在不同频率 (tid, bid, qd) 并将结果与未接受治疗的组进行比较.
主要成果:
- 皮洛卡治疗导致SNOT-22得分在6个月和停药后显著降低.
- 皮洛卡尔治疗的小组在SNOT-22分数中显示了持续的改善.
- 较低剂量方案证明了有效性,与5毫克二次相比,副作用减少.
结论:
- 皮洛卡是ARS中耐火性鼻腔阻塞的可行的治疗选择.
- 高剂量 (5毫克) 的副作用很常见,这表明更低的调整剂量是可取的.
- 皮洛卡尔治疗症状的改善可以在停止治疗后维持在适当的剂量下.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.9K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.9K
Drugs Used in Upper Respiratory Disorders: Overview
835
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
835
Epistaxis
691
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
691
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.2K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.2K
Ophthalmic Drug Delivery Systems
154
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
154


